Medicines Out Of Control
Download Medicines Out Of Control full books in PDF, epub, and Kindle. Read online free Medicines Out Of Control ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Charles Medawar |
Publisher | : Aksant Academic Publishers |
Total Pages | : 0 |
Release | : 2004 |
Genre | : Antidepressants |
ISBN | : 9789052601342 |
"This is a narrative about a drug crisis still in the making. The story is mainly about the control and consumption of mood-regulating drugs, antidepressants like Prozac. The evidence from this story points to a much wider problem - sickening human dependence on corporate and professional power." "It describes the moments and events that led to the setting up a government enquiry on the risks of drug-induced dependence and suicidal behaviour with antidepressants. It provides context for the findings of this enquiry, and reviews the limitations of a drug safety system in which the regulators routinely investigate what others might conclude to be their mistakes." "Medicines out of Control? is a discourse on the safety of medicines and the ethos of pharmaceutical medicine - and their impact on personal safety and health."--BOOK JACKET.Title Summary field provided by Blackwell North America, Inc. All Rights Reserved
Author | : Professor Richard Taylor |
Publisher | : Palgrave |
Total Pages | : 292 |
Release | : 1980-11 |
Genre | : Medical |
ISBN | : 9780333306239 |
Author | : Marcia Angell |
Publisher | : Random House Digital, Inc. |
Total Pages | : 346 |
Release | : 2004 |
Genre | : Business & Economics |
ISBN | : |
During her two decades at "The New England Journal of Medicine," Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. Written with fierce passion and substantiated with in-depth research, "The Truth About the Drug Companies" is her searing indictment of an industry that has spun out of control.
Author | : Katherine Eban |
Publisher | : HarperCollins |
Total Pages | : 512 |
Release | : 2020-06-23 |
Genre | : Medical |
ISBN | : 0063054108 |
A NEW YORK TIMES BESTSELLER New York Times 100 Notable Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Best Books of 2019 New postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 80 |
Release | : 2009 |
Genre | : Medical |
ISBN | : 9241547693 |
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Author | : Peter Gotzsche |
Publisher | : CRC Press |
Total Pages | : 251 |
Release | : 2019-08-21 |
Genre | : Medical |
ISBN | : 1908911123 |
PRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the pharmaceutical industries and their charade of fraudulent behaviour, both in research and marketing where the morally repugnant disregard for human lives is the norm. He convincingly draws close co
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 175 |
Release | : 2019-06-16 |
Genre | : Medical |
ISBN | : 0309486483 |
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Author | : Dean T. Jamison |
Publisher | : World Bank Publications |
Total Pages | : 1449 |
Release | : 2006-04-02 |
Genre | : Medical |
ISBN | : 0821361805 |
Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.
Author | : William N. Brownsberger |
Publisher | : Harvard University Press |
Total Pages | : 284 |
Release | : 2009-06-30 |
Genre | : Medical |
ISBN | : 0674038622 |
This book is the culmination of five years of debate among distinguished scholars in law, public policy, medicine, and biopsychology, about the most difficult questions in drug policy and the study of addictions. Do drug addicts have an illness, or is the addiction under their control? Should they be treated as patients or as criminals? Challenging the conventional wisdom, the authors show that these standard dichotomies are false.
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 483 |
Release | : 2017-09-28 |
Genre | : Medical |
ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.